BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4257050)

  • 1. [Use of a polyacrylamide gel gradient for the separation of fibrinogen degradation products. Sensitivity of the immunological reaction of hemagglutination inhibition. Merskey's test on various isolated fragments].
    Soria J; Fabiani P
    Ann Biol Clin (Paris); 1971; 29(4):303-7. PubMed ID: 4257050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Detection of serum fibrinogen degradation products using Merskey's technic, Apropos of 169 cases].
    Kolodié L; Seigneurin D; Micouin C; Hollard D
    Pathol Biol (Paris); 1974 Nov; 22 suppl():66-71. PubMed ID: 4219980
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological measurement of fibrinogen and its derivatives].
    Maki M
    Rinsho Byori; 1967 Sep; 15(9):627-33. PubMed ID: 4968899
    [No Abstract]   [Full Text] [Related]  

  • 4. The Tanned Red Cell Hemagglutination Inhibition Immunoassay and purified fibrinogen degradation products.
    Donati MB; Molla A; Vermylen J
    Scand J Haematol Suppl; 1971; 13():91-9. PubMed ID: 4258208
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antisera to fibrinogen degradation products, fragments D and E].
    Sudo T; Fujisawa M; Okumura H; Manita H
    Nihon Ketsueki Gakkai Zasshi; 1972 Oct; 35(5):652-3. PubMed ID: 4269798
    [No Abstract]   [Full Text] [Related]  

  • 6. [Application of immunologic methods and the Kissmeyer-Nielsen reaction for the detection of fibrinogen and the products of fibrinolysis].
    Gulmantowicz AH; Lodi R
    Schweiz Med Wochenschr; 1966 Sep; 96(37):1194-6. PubMed ID: 4967634
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemagglutination inhibition (Merskey's test) in consumption coagulopathies. Apropos of 101 patients].
    Soria J; Soria C; Yver J; Girard ML; Samama M; Bilski-Pasquier G
    Presse Med (1893); 1971 May; 79(22):1003-6. PubMed ID: 5281042
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
    Loly W; Israels LG; Bishop AJ; Israels ED
    Thromb Diath Haemorrh; 1971 Dec; 26(3):526-40. PubMed ID: 4259443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
    Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
    Lab Delo; 1978; (5):259-66. PubMed ID: 79007
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrofocusing of abnormal fibrinogens in polyacrylamide gel].
    Soria J; Soria C; Durand G; Feger J
    Ann Biol Clin (Paris); 1972; 30(2):161-5. PubMed ID: 5040625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinogen and its degradation products in the synovial fluid of 100 rheumatic patients and its comparison with the proteinogram and immunodiffusion].
    Menchón Galiana M; Serra Mercader JM; López Dasi JL; Barceló P; Fargas R
    Rev Esp Reum Enferm Osteoartic; 1975; 18(1):30-80. PubMed ID: 806107
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen degradation products: a critical study of two assay methods.
    Thuot C; Larrieu MJ
    Rev Eur Etud Clin Biol; 1971; 16(1):27-34. PubMed ID: 4252113
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the use of glutaraldehyde for the sensitization of red cells in Merskey's technic].
    Quichaud C; de Cacqueray-Joigny C; Etcharry F; Moras M; Chatelan M; Boisseau M; Bentegeat J
    Pathol Biol (Paris); 1974 Nov; 22 suppl():92-6. PubMed ID: 4219981
    [No Abstract]   [Full Text] [Related]  

  • 14. Tanned Red Cell Hemagglutination Inhibition Immunoassay for fibrinogen-fibrin-related antigen ("fibrinolytic degradation products") in human serum.
    Merskey C; Lalezari P; Johnson AJ
    Scand J Haematol Suppl; 1971; 13():83-5. PubMed ID: 5290706
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental study of rabbit fibrinogen degradation products. Influence of plasminogen level for the interpretation of serum concentration of fibrinogen degradation products in consumption coagulopathies.
    Soria J; Soria C; Vairel E; Prost RJ; Warneson G
    Thromb Diath Haemorrh; 1973 Feb; 29(1):115-21. PubMed ID: 4267735
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
    [No Abstract]   [Full Text] [Related]  

  • 17. Properties of fibrinogenolysis and fibrinolysis products in immune assays.
    Beller FK; Maki M
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):114-32. PubMed ID: 4229208
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogen break-down products and clotting parameters.
    Gormsen J; Laursen B
    Thromb Diath Haemorrh; 1967 May; 17(3-4):467-81. PubMed ID: 4231951
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the degradation of fibrinogen by proteolytic enzymes from the larvae of Lanomia achelous (Cramer).
    Arocha-Piñango CL; Perales J; Carvajal Z
    Thromb Haemost; 1981 Jun; 45(3):233-6. PubMed ID: 6456570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet fibrinogen. Identity and initial observations on the mode of its degradation by plasmin.
    James HL; Bradford HR; Ganguly P
    Biochim Biophys Acta; 1975 Mar; 386(1):209-20. PubMed ID: 236019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.